WebFeb 15, 2024 · Biogen Inc. (NASDAQ:NASDAQ:BIIB) Q4 2024 Results Conference Call February 15, 2024 8:00 AM ETCompany ParticipantsMike Hencke - Head, Investor … WebNov 27, 2024 · On Monday, November 30 at 9:00 a.m. ET, Biogen will host a live conference call to discuss the collaboration, ... BIOGEN INVESTOR CONTACT: Joe Mara Biogen Inc. Tel: (781) 464-2442
Sage Therapeutics and Biogen Announce that the ... - Investor …
WebMar 30, 2024 · CAMBRIDGE, Mass., March 14, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (NASDAQ: BIIB) today announced the appointment of Chuck Triano as Senior Vice … All SEC filings (excluding Section 16 ownership and Form 144 Filings) 2024 Annual Report. 2024 Annual Report 10.7 MB. April 23, 2024 ( FY 2024) Conference and Other Investor Presentations. ... Dec 06, 2024. Biogen … Biogen is a leading global biotechnology company that pioneers science and … View HTML: Apr 04, 2024: Filed by "insiders" prior intended sale of … Sage Therapeutics and Biogen to Host Investor Webcast on December 6, 2024 … WebNov 30, 2024 · Biogen Inc. (NASDAQ:NASDAQ:BIIB) Biogen and Sage Collaboration Conference Call November 30, 2024 9:00 AM ETCompany ParticipantsJoe Mara - Vice President, Investor RelationsMichel Vounatsos... great knoutberry hill walk
Biogen and Ionis Expand Strategic Collaboration to Develop Drug ...
WebOct 20, 2024 · Good morning and welcome to Biogen's third quarter 2024 earnings call. Before we begin I encourage everyone to go to the Investors section of biogen.com to find the earnings release and related financial tables, including our GAAP financial measures and a reconciliation of the GAAP to non-GAAP financial measures that we will discuss … WebMay 2, 2024 · BIOGEN MEDIA CONTACT: Ashleigh Koss Tel: +1 908-205-2572 [email protected]. SAGE INVESTOR CONTACT: Helen Rubinstein (315) 382-3979 [email protected]. BIOGEN INVESTOR CONTACT: Mike Hencke +1 781 464 2442 [email protected]. Source: Sage Therapeutics, Inc. WebNov 30, 2024 · Investors may email [email protected] or call 617-531-3917. Interested Biogen investors have until January 12, 2024 to apply to be a lead plaintiff. Interested Biogen investors have until ... great knowledge or learning crossword